Evidence map›Paper›PMID 39557992›Full record

ArticleScientific reports2024

Comparison between spectral-domain optical coherence tomography-based and partial coherence interferometry-based biometry.

So Min Ahn, Young Ho Kim, Cheolmin Yun, Jaeryung Oh

Abstract readComparative Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

So Min AhnDepartment of Ophthalmology, Dongguk University Ilsan Hospital, Goyang, South Korea.
Young Ho KimDepartment of Ophthalmology, Korea University College of Medicine, Seoul, Korea.
Cheolmin YunDepartment of Ophthalmology, Korea University College of Medicine, Seoul, Korea.
Jaeryung OhDepartment of Ophthalmology, Korea University College of Medicine, Seoul, Korea. ojr4991@korea.ac.kr.

Funding

Korea Medical Device Development Fund 171137942
6 · The paper itself

Abstract

We compared axial length (AL) measurements using spectral-domain optical coherence tomography (SD-OCT)-based and partial coherence interferometry (PCI)-based biometry in eyes with various chorioretinal diseases. Medical records were retrospectively analyzed in 123 eyes from 73 patients who underwent AL measurements using SD-OCT and PCI. AL values were highly consistent by both measurements (ICC = 0.996 in SD-OCT and 0.995 in PCI-based biometry). The mean difference in AL between the two instruments was - 0.09 ± 0.17 mm, which was significant (P < 0.001). There was a strong correlation between the measurements obtained using the two instruments (r = 0.982, P < 0.001). The 95% limits of agreement were - 0.43 to 0.25 mm, and the agreement of AL in the Bland-Altman analysis showed a difference. The difference in measurements was not associated with the difference in central retinal thickness (r = 0.033, P = 0.720). However, the presence of an epiretinal membrane affected the difference in measurements, unlike in other chorioretinal diseases (P = 0.014). SD-OCT-based biometry showed a good correlation with PCI-based biometry in the measurement of AL; however, the mean AL between the two instruments was significantly different. Therefore, AL measurements made using SD-OCT-based and PCI-based biometry are not interchangeable.

Indexed as

BiometryInterferometryTomography, Optical CoherenceAdultAgedAged, 80 and overAxial Length, EyeFemaleHumansMaleMiddle AgedRetinaRetinal DiseasesRetrospective StudiesAxial lengthCorrelation Chorioretinal diseaseOptical coherence tomographyPartial coherence interferometry

Identifiers

PMID39557992
PMCPMC11574078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.